Simon N. Pimstone, Director at Xenon Pharmaceuticals Inc. (XENE), sold 2,500 shares at $30.80 ($77K) on 2022-03-08, disclosed to the SEC on 2022-03-08.
Open-market sale of $77k XENE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| XENE | SELL | 2022-08-16 | $10.9M | — | Filing → |
| XENE | SELL | 2022-03-08 | $2.2M | — | Filing → |
| XENE | SELL | 2021-11-16 | $1.1M | — | Filing → |